Denosumab is a medication that is primarily used to treat osteoporosis, a condition characterized by weak and brittle bones. It is also used to prevent skeletal-related events (such as fractures) in patients with bone metastases from solid tumors. Denosumab is a monoclonal antibody, a type of protein that specifically targets and binds to a certain molecule in the body. To learn more about its long term benefits and consideration for optimal health, join Dr Rajesh Malhotra and Dr Nitin Kapoor on June 24 at 8:00 p.m.
Dr. (Prof.) Nitin Kapoor
Professor in Endocrinology, Department of Endocrine, Diabetes and Metabolism, Christian Medical collage, Vellore, India
Dr. Rajesh Malhotra
Professor & Head of Orthopaedics & Chief, J P N Apex Trauma Centre, AIIMS, New Delhi
